Comparison of thallium-201 and gallium-67 scintigraphy in soft tissue and bone marrow multiple myeloma: A case report

Australasian Radiology

Volumn 41, Issue 1, 1997, Pages 67-69

  Roach, Paul J ^a   Arthur, Christopher K ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Gallium 67; Multiple myeloma; Thallium 201

Indexed keywords

ALLOPURINOL; CYCLOPHOSPHAMIDE; GALLIUM 67; MELPHALAN; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISONE; THALLIUM 201; VINDESINE;

AGED; ARTICLE; BONE MARROW CANCER; CASE REPORT; FEMALE; HUMAN; MULTIPLE MYELOMA; PRIORITY JOURNAL; SOFT TISSUE CANCER; WHOLE BODY SCINTISCANNING;

EID: 0030992161     PISSN: 00048461     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1673.1997.tb00474.x     Document Type: Article

References (17)

1. Lee VW, Sachs EJ, McAnemy DB et al. A complimentary role of Thallium-201 scintigraphy and mammography in the diagnosis of breast cancer. J. Nucl. Med. 1993; 34: 2095-100.
2. Dadparvar S, Koishna L, Brady LW et al. The role of I-131 and Thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid cancer. Cancer 1993; 71: 2767-73.
3. Hisada K, Tomami N, Miyamae T et al. Clinical evaluation of tumour imaging with Thallium-201 Chloride. Radiology 1978; 129: 497-500.
4. Woolfenden JM, Pitt MJ, Durie BGM, Moon TE. Comparison of bone scintigraphy and radiography in multiple myeloma. Radiology 1980; 134: 723-6.
5. Kyle RA. Multiple myeloma: Review of 869 cases. Mayo Clin. Proc. 1975; 50: 29-40.
6. Posch TJ, Olson SP. Marked soft tissue uptake of bone tracer in a patient with amyloidosis and multiple myeloma. Clin. Nucl. Med. 1992; 17: 909.
7. Beckerman V, Hoffer P, Bitran J. Gallium-67 Citrate scanning in oncology. Semin. Nucl. Med. 1984; 14: 296-323.
8. Waxman AD, Siemsen JK, Levine AM et al. Radiographic and radionuclide imaging in multiple myeloma: The role of gallium scintigraphy; concise communication. J. Nucl. Med. 1981; 22: 232-6.
9. Huvner KF, Andrews GA, Haiz RL, Poggenburg JK, Solomon A. The use of rare earth radionuclides and other bone seekers in the evaluation of bone lesions in patients with multiple myeloma or solitary plasmacytoma. Radiology 1977; 125: 171-6.
10. Ohnishi T, Noguchi S, Murakimi N et al. Pentavalent Tc-99m DMSA uptake in a patient having multiple myeloma without amyloidosis. J. Mucl. Med. 1991; 32: 1785-7.
11. Ohta H, Endo K, Kanoh T et al. Tc-99m (V) DMSA uptake in amyloidosis. J. Nucl. Med. 1989; 30: 2049-52.
12. Waxman AD. Thallium-201 in nuclear oncology. In: Freeman LM (ed.). Nuclear Medicine Annual 1991. Raben Press, New York, 1991: 37-74.
13. Sessler MJ, Geck P, Maul FD et al. New aspects of cellular Thallium-201 uptake: Co-transport is the central mechanism of iron uptake. J. Nucl. Med. 1986; 25: 24-7.
14. Sehwerl AM, McKillop JH, Milroy R et al. Mechanism of Thallium-201 uptake in tumours. Eur. J. Nucl. Med. 1989; 15: 376-9.
15. Sayman HB, Sonmezoglu K, Altiok E, Debranoglu G, Ferhanoglu B. Unexpected bone marrow uptake of Thallium-201 in nonsecretory myeloma. J. Nucl. Med. 1995; 36: 250-1.
16. Abdel-Dayeem HM, Sanchez J, Al-Mohammadi S, Kempf J. Diffuse Thallium-201 Chloride uptake in hypermetabolic bone marrow following treatment with granulocytic stimulating factor. J. Nucl. Med. 1992; 33: 2014-16.
17. Roach PJ, Janicek MJ, Kaplan WD. Comparison of thallium-201 and gallium-67 in the evaluation of non-Hodgkin's Lymphoma involving bone. Aust. N.Z. J. Med. (in press).